May 05, 2021
Many years ago I treated a patient with a rare sarcoma. We recently reconnected and she generously shared her experience of being treated for and now considered "cured" of her rare tumor, with a reminder that the cancer experience is unique to every individual.
May 04, 2021
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Apr 27, 2021
With the current pace of progress in cancer care, urgent implementation of cost-effectiveness training curriculum in fellowship training programs will be indispensable, shares Dr. Samer Al Hadidi.
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
Meaningful Progress Against Gastric, Pancreatic, and Colorectal Cancers Reported at the 2014 Gastrointestinal Cancers Symposium
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...